-
Something wrong with this record ?
Assessing average somatic CAG repeat instability at the protein level
H. Aviolat, RM. Pinto, E. Godschall, R. Murtha, HE. Richey, E. Sapp, P. Vodicka, VC. Wheeler, KB. Kegel-Gleason, M. DiFiglia,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Nature Open Access
from 2011-12-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-12-01
- MeSH
- DNA genetics MeSH
- Exons genetics MeSH
- Trinucleotide Repeat Expansion genetics MeSH
- Humans MeSH
- Mice, Inbred C57BL MeSH
- Mice, Transgenic MeSH
- Peptides genetics MeSH
- Huntingtin Protein chemistry genetics MeSH
- Antibodies metabolism MeSH
- Amino Acid Sequence MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Sandwich ELISA-based methods use Abs that target the expanded polyglutamine (polyQ) tract to quantify mutant huntingtin (mHTT). Using Meso Scale Discovery (MSD) assay, the mHTT signal detected with MW1 Ab correlated with polyQ length and doubled with a difference of only 7 glutamine residues between equivalent amounts of purified mHTTexon1 proteins. Similar polyQ length-dependent effects on MSD signals were confirmed using endogenous full length mHTT from brains of Huntington's disease (HD) knock-in (KI) mice. We used this avidity bias to devise a method to assess average CAG repeat instability at the protein level in a mixed population of HTT proteins present in tissues. Signal detected for average polyQ length quantification at the protein level by our method exhibited a strong correlation with average CAG repeat length at the genomic DNA level determined by PCR method in striatal tissue homogenates from HdhQ140 KI mice and in human HD postmortem cortex. This work establishes that CAG repeat instability in mutant HTT is reflected at the protein level.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028707
- 003
- CZ-PrNML
- 005
- 20210114154810.0
- 007
- ta
- 008
- 210105s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-019-55202-x $2 doi
- 035 __
- $a (PubMed)31844074
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Aviolat, Hubert $u Department of Neurology, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- 245 10
- $a Assessing average somatic CAG repeat instability at the protein level / $c H. Aviolat, RM. Pinto, E. Godschall, R. Murtha, HE. Richey, E. Sapp, P. Vodicka, VC. Wheeler, KB. Kegel-Gleason, M. DiFiglia,
- 520 9_
- $a Sandwich ELISA-based methods use Abs that target the expanded polyglutamine (polyQ) tract to quantify mutant huntingtin (mHTT). Using Meso Scale Discovery (MSD) assay, the mHTT signal detected with MW1 Ab correlated with polyQ length and doubled with a difference of only 7 glutamine residues between equivalent amounts of purified mHTTexon1 proteins. Similar polyQ length-dependent effects on MSD signals were confirmed using endogenous full length mHTT from brains of Huntington's disease (HD) knock-in (KI) mice. We used this avidity bias to devise a method to assess average CAG repeat instability at the protein level in a mixed population of HTT proteins present in tissues. Signal detected for average polyQ length quantification at the protein level by our method exhibited a strong correlation with average CAG repeat length at the genomic DNA level determined by PCR method in striatal tissue homogenates from HdhQ140 KI mice and in human HD postmortem cortex. This work establishes that CAG repeat instability in mutant HTT is reflected at the protein level.
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protilátky $x metabolismus $7 D000906
- 650 _2
- $a DNA $x genetika $7 D004247
- 650 _2
- $a exony $x genetika $7 D005091
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a protein huntingtin $x chemie $x genetika $7 D000071058
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a myši transgenní $7 D008822
- 650 _2
- $a peptidy $x genetika $7 D010455
- 650 _2
- $a expanze trinukleotidových repetic $x genetika $7 D019680
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pinto, Ricardo Mouro $u Department of Neurology, Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- 700 1_
- $a Godschall, Elizabeth $u Department of Neurology, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- 700 1_
- $a Murtha, Ryan $u Department of Neurology, Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- 700 1_
- $a Richey, Hannah E $u Department of Neurology, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- 700 1_
- $a Sapp, Ellen $u Department of Neurology, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- 700 1_
- $a Vodicka, Petr $u Department of Neurology, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Research Center PIGMOD, Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, Libechov, Czech Republic.
- 700 1_
- $a Wheeler, Vanessa C $u Department of Neurology, Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- 700 1_
- $a Kegel-Gleason, Kimberly B $u Department of Neurology, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- 700 1_
- $a DiFiglia, Marian $u Department of Neurology, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. difiglia@helix.mgh.harvard.edu.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 9, č. 1 (2019), s. 19152
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31844074 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114154807 $b ABA008
- 999 __
- $a ok $b bmc $g 1609042 $s 1119887
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 9 $c 1 $d 19152 $e 20191216 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20210105